Congenica (Group)

https://www.congenica.com

Congenica is a digital health company enabling the rapid analysis and interpretation of genomic data, empowering researchers to provide life-changing answers that will in future improve wellbeing and disease management. Congenica’s world-leading software enables rapid genomic data analysis at scale, performing 20x faster than industry averages and providing a 30% higher analytical yield, reducing genomic interpretation costs by up to 95%. Born out of pioneering research from the Wellcome Sanger Institute and the NHS, Congenica has a global footprint supporting leading international laboratories, academic medical centres and biopharmaceutical companies and is the exclusive Clinical Decision Support partner for the NHS Genomic Medicine Service. *

	Start	2014-05-03 existent
	Predecessor	Sanger Institute, The Wellcome Trust
	Industry	Sapientia™ clinical genomics analytics platform
	Industry 2	genomics
	Person	Atkins, David (Congenica 201801– CEO before Synevo + Leica Biosystems + JnJ/Ortho Clinical Diagnostics)
	Person 2	Weaver, Tom (Congenica 201309– CEO before MRC + Source BioScience formerly Medical Solutions + Geneservice)

	Region	Hinxton, Cambridgeshire
	Country	United Kingdom (GB)
	Street	Wellcome Trust Genome Campus Wellcome Trust Genome Campus
	City	CB10 1DR Cambridge
	Tel	+44-1223-499965
		Address record changed: 2020-12-02

Basic data	Employees	n. a.

		* Document for ï¿½About Sectionï¿½: Congenica Ltd.. (11/9/20). "Press Release: Congenica Completes $50m Series C Funding Round to Advance Clinical Genomic Analysis Software and Data Platform". Cambridge.

		Record changed: 2021-01-14